Posted by law663 on December 30, 2005, at 17:41:08
In reply to Re: Effexor metabolite submitted for FDA approval » TrishP, posted by Larry Hoover on December 29, 2005, at 9:17:26
I've read with interest this thread. I agree with Linkage and Sonny -- this is nothing to be excited about. Just another way to extend the effexor patent. The problem as I see it is that there is no real carrot for a drug company to develop a truely novel compound when then can get a 20 year patent on a simple spin off. Perhaps a graduated patent system would be better -- really novel compounds could get 20 years, crap like celexa 5 years. Of course, who decides would be an issue, but I don't know anyone where I work who's excited about this latest AD or any that are likely to be in the pipeline for the next 5 years.
poster:law663
thread:591573
URL: http://www.dr-bob.org/babble/20051221/msgs/593525.html